302 related articles for article (PubMed ID: 15644321)
21. Differential involvement of p38 mitogen-activated protein kinase kinases MKK3 and MKK6 in T-cell apoptosis.
Tanaka N; Kamanaka M; Enslen H; Dong C; Wysk M; Davis RJ; Flavell RA
EMBO Rep; 2002 Aug; 3(8):785-91. PubMed ID: 12151339
[TBL] [Abstract][Full Text] [Related]
22. MEK2 controls the activation of MKK3/MKK6-p38 axis involved in the MDA-MB-231 breast cancer cell survival: Correlation with cyclin D1 expression.
Huth HW; Albarnaz JD; Torres AA; Bonjardim CA; Ropert C
Cell Signal; 2016 Sep; 28(9):1283-1291. PubMed ID: 27181679
[TBL] [Abstract][Full Text] [Related]
23. MKK3-p38 signaling promotes apoptosis and the early inflammatory response in the obstructed mouse kidney.
Ma FY; Tesch GH; Flavell RA; Davis RJ; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1556-63. PubMed ID: 17686961
[TBL] [Abstract][Full Text] [Related]
24. Mitogen-activated protein kinase kinase 3 is a pivotal pathway regulating p38 activation in inflammatory arthritis.
Inoue T; Boyle DL; Corr M; Hammaker D; Davis RJ; Flavell RA; Firestein GS
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5484-9. PubMed ID: 16567640
[TBL] [Abstract][Full Text] [Related]
25. Activation of the p38 mitogen-activated protein kinase by type I interferons.
Uddin S; Majchrzak B; Woodson J; Arunkumar P; Alsayed Y; Pine R; Young PR; Fish EN; Platanias LC
J Biol Chem; 1999 Oct; 274(42):30127-31. PubMed ID: 10514501
[TBL] [Abstract][Full Text] [Related]
26. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38alpha and p38delta MAPK isoforms by TGF-beta 1 in murine mesangial cells.
Wang L; Ma R; Flavell RA; Choi ME
J Biol Chem; 2002 Dec; 277(49):47257-62. PubMed ID: 12374793
[TBL] [Abstract][Full Text] [Related]
27. Role of Stat5 in type I interferon-signaling and transcriptional regulation.
Uddin S; Lekmine F; Sassano A; Rui H; Fish EN; Platanias LC
Biochem Biophys Res Commun; 2003 Aug; 308(2):325-30. PubMed ID: 12901872
[TBL] [Abstract][Full Text] [Related]
28. p150(Glued), Dynein, and microtubules are specifically required for activation of MKK3/6 and p38 MAPKs.
Cheung PY; Zhang Y; Long J; Lin S; Zhang M; Jiang Y; Wu Z
J Biol Chem; 2004 Oct; 279(44):45308-11. PubMed ID: 15375157
[TBL] [Abstract][Full Text] [Related]
29. MKK6 deficiency promotes cardiac dysfunction through MKK3-p38γ/δ-mTOR hyperactivation.
Romero-Becerra R; Mora A; Manieri E; Nikolic I; Santamans AM; Montalvo-Romeral V; Cruz FM; Rodríguez E; León M; Leiva-Vega L; Sanz L; Bondía V; Filgueiras-Rama D; Jiménez-Borreguero LJ; Jalife J; Gonzalez-Teran B; Sabio G
Elife; 2022 Aug; 11():. PubMed ID: 35971771
[TBL] [Abstract][Full Text] [Related]
30. Expression and activation of mitogen-activated protein kinase kinases-3 and -6 in rheumatoid arthritis.
Chabaud-Riou M; Firestein GS
Am J Pathol; 2004 Jan; 164(1):177-84. PubMed ID: 14695331
[TBL] [Abstract][Full Text] [Related]
31. Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses.
Giafis N; Katsoulidis E; Sassano A; Tallman MS; Higgins LS; Nebreda AR; Davis RJ; Platanias LC
Cancer Res; 2006 Jul; 66(13):6763-71. PubMed ID: 16818652
[TBL] [Abstract][Full Text] [Related]
32. MKK3, an upstream activator of p38, contributes to formalin phase 2 and late allodynia in mice.
Sorkin LS; Boyle DL; Hammaker D; Herman DS; Vail E; Firestein GS
Neuroscience; 2009 Aug; 162(2):462-71. PubMed ID: 19427893
[TBL] [Abstract][Full Text] [Related]
33. Fragment-based drug discovery of potent and selective MKK3/6 inhibitors.
Adams M; Kobayashi T; Lawson JD; Saitoh M; Shimokawa K; Bigi SV; Hixon MS; Smith CR; Tatamiya T; Goto M; Russo J; Grimshaw CE; Swann S
Bioorg Med Chem Lett; 2016 Feb; 26(3):1086-1089. PubMed ID: 26704264
[TBL] [Abstract][Full Text] [Related]
34. c-Abl-induced apoptosis, but not cell cycle arrest, requires mitogen-activated protein kinase kinase 6 activation.
Cong F; Goff SP
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13819-24. PubMed ID: 10570156
[TBL] [Abstract][Full Text] [Related]
35. Regulation of the transcriptional activity of the IRF7 promoter by a pathway independent of interferon signaling.
Ning S; Huye LE; Pagano JS
J Biol Chem; 2005 Apr; 280(13):12262-70. PubMed ID: 15664995
[TBL] [Abstract][Full Text] [Related]
36. Developmental regulation of mitogen-activated protein kinase-activated kinases-2 and -3 (MAPKAPK-2/-3) in vivo during corpus luteum formation in the rat.
Maizels ET; Mukherjee A; Sithanandam G; Peters CA; Cottom J; Mayo KE; Hunzicker-Dunn M
Mol Endocrinol; 2001 May; 15(5):716-33. PubMed ID: 11328854
[TBL] [Abstract][Full Text] [Related]
37. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6.
Enslen H; Raingeaud J; Davis RJ
J Biol Chem; 1998 Jan; 273(3):1741-8. PubMed ID: 9430721
[TBL] [Abstract][Full Text] [Related]
38. Protein kinase C-delta (PKC-delta ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727.
Uddin S; Sassano A; Deb DK; Verma A; Majchrzak B; Rahman A; Malik AB; Fish EN; Platanias LC
J Biol Chem; 2002 Apr; 277(17):14408-16. PubMed ID: 11839738
[TBL] [Abstract][Full Text] [Related]
39. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
Otto KB; Acharya SS; Robinson VL
Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
[TBL] [Abstract][Full Text] [Related]
40. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia.
Tanno M; Bassi R; Gorog DA; Saurin AT; Jiang J; Heads RJ; Martin JL; Davis RJ; Flavell RA; Marber MS
Circ Res; 2003 Aug; 93(3):254-61. PubMed ID: 12829618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
